Lilly to pay up to $370M for OmniAb collab; Slate, Fulcrum forge reverse merger
🤝 OmniAb’s Lilly pact: The California drug discovery shop has an ion channel collaboration and licensing agreement in place with the GLP-1 giant. Eli Lilly will pay up to $370 million ...
August 17, 2026 10:36 AM EDT News Briefing Lilly to pay up to $370M for OmniAb collab; Slate, Fulcrum forge reverse merger Kyle LaHucik Biotech Correspondent 🤝 OmniAb’s Lilly pact: The California drug discovery shop has an ion channel collaboration and licensing agreement in place with the GLP-1 giant. Eli Lilly … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that